logo
  

FirstGroup Sees Annual Adj. Profit To Be Ahead Of Previous Expectations; Backs 2024 View

FirstGroup Plc (FGROY.PK,FGROF.PK,FGP.L), a British transport company, said on Friday that it expects full-year earnings to be ahead of its previous expectations, supported by higher passenger volumes and demand in the ongoing second-half.

However, the company's expectations for 2024 remain unchanged.

Graham Sutherland, CEO of FirstGroup, said: "I am pleased by the Group's progress in the second half of our 2023 financial year, which has been driven by increased passenger volumes and improved operational performance in bus and stronger than anticipated demand for our open access operations in rail..."

The Group now projects that its 2023 adjusted operating profit and adjusted profit will be ahead of its previous expectations.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT